WHAT’S NEW
Novel biomarkers are needed in the prognosis and treatment process of
the disease. There has been no report about thiol levels in pulmonary
thromboembolism patients, so far. To our knowledge, this study is the
first study that investigates thiols and thiol/disulphide homeostasis in
patients with pulmonary thromboembolism (with subgroups). For this
purpose, determination of dynamic thiol/disulphide status in diseases
where oxidative stress plays a major role in pathogenesis would be
important.